As accessible health care providers, pharmacists can raise awareness about the proper use of OTC blood glucose meters and continuous glucose monitoring devices.
|Articles|July 1, 2004
- Volume 0 0
Agreement Provides Funding for Graduate Education
Advertisement
The American Association of Pharmaceutical Scientists (AAPS) has enteredinto an agreement with Cardinal Health to help support educational opportunitiesin the pharmaceutical sciences. The partnership establishes funding for 300graduate and postdoctoral students toward membership in the association.
"One of the best ways AAPS can advance the future direction of the pharmaceuticalsciences is to actively recruit and involve the students of today," saidAAPS President Mario Rocci, PhD.
AAPS has >1200 student and 240 postdoctoral members and supports 34chapters at Schools of Pharmacy in the United States and Canada. The AAPSchapters allow students to increase their awareness of career opportunities in thepharmaceutical sciences and gain access to educational opportunities.
Articles in this issue
over 22 years ago
Bloodstream Infection Risk Is Higher for Diabeticsover 22 years ago
Research Links Diabetes with Alzheimer'sover 22 years ago
Individuals with Chronic Pain Keep Quietover 22 years ago
Association Redesigns Web Siteover 22 years ago
Fibromyalgia Hits Individuals Differentlyover 22 years ago
Procedure May Relieve Agony of Spinal Cord Injuriesover 22 years ago
Europeans Are Slow to Seek Treatmentover 22 years ago
Intervention Curbs Asthma in Childrenover 22 years ago
Vaccine at Birth May Diminish Allergiesover 22 years ago
Asthma in Women Is Greater with Acetaminophen UseNewsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
SubscribeAdvertisement
Related to this article
Growing evidence points to gallstones and cholecystitis as an underrecognized risk of GLP-1 RA therapy—pharmacists are well positioned to catch it early.
As earning years peak, so do spending and responsibility—here’s where midcareer pharmacists should focus their financial decision-making.
Despite the controversy surrounding mRNA's role in the COVID-19 response, the technology's broader promise—to prevent, treat, and even cure a host of diseases—is coming into focus.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Rising Gallbladder Complications With GLP-1 Receptor Agonists Call for Closer Pharmacist Monitoring
2
Using CKDintercept to Build Interdisciplinary Kidney Care
3
The Value of Self-Monitoring Blood Glucose Tools in Preventing and Reducing Prediabetes and Diabetes-Related Complications
4
Who "Owns" CKD? Making the Case for Co-Management and Patient Empowerment
5